Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose

Hypoxia is a characteristic feature of solid tumors and an important causation of resistance to chemotherapy and photodynamic therapy (PDT). It is challenging to develop efficient functional nanomaterials for tumor oxygenation and therapeutic applications. Methods: Through disulfide reconfiguration...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Theranostics
Autori principali: Luo, Zhenyu, Tian, Hao, Liu, Lanlan, Chen, Zhikuan, Liang, Ruijing, Chen, Ze, Wu, Zhihao, Ma, Aiqing, Zheng, Mingbin, Cai, Lintao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ivyspring International Publisher 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037038/
https://ncbi.nlm.nih.gov/pubmed/30026868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.25409
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi